Announce Date | 02/12/2025 |
EPS Normalized Actual | $0.94 (Beat by $0.03) |
EPS GAAP Actual | $0.94 (Beat by $0.03) |
Revenue Actual | $13.991B |
Revenue Surprise | Beat by $13991M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jul 2027 | 0 | INF | 0 | 0 | 7 |
Jul 2026 | 3.68107 | 16.23 | 3.44 | 4.10788 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Jan 2025) | -0.68 | -0.68 | 13.991B | 100% | 13991M |
FQ4 2024 (Oct 2024) | 0.68 | 0.68 | 13.841B | -5.98% | 13841M |
FQ3 2024 (Jul 2024) | 0.54 | 0.54 | 13.642B | -11.44% | 13642M |
FQ2 2024 (Apr 2024) | 0.47 | 0.47 | 12.702B | 100% | 12702M |
FQ1 2024 (Jan 2024) | 0 | 0 | 0B | -INF% | 0M |
FQ4 2023 (Oct 2023) | 0.9 | 0.9 | 14.668B | 100% | 14668M |
FQ3 2023 (Jul 2023) | 0.97 | 0.97 | 15.203B | 100% | 15203M |
FQ3 1993 (Jul 1993) | 0 | 0 | 0.2052B | 100% | 205.2M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Jul 2027) | 1.12173 | -- | 1.11416 | 1.13281 | 9 |
FQ2 2027 (Apr 2027) | 1.07736 | -- | 1.07009 | 1.08801 | 9 |
FQ1 2027 (Jan 2027) | 1.04157 | -- | 1.01319 | 1.05961 | 3 |
FQ4 2026 (Oct 2026) | 1.04782 | -- | 1.04075 | 1.05817 | 9 |
FQ3 2026 (Jul 2026) | 1.15223 | -- | 1.11372 | 1.24488 | 9 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Jul 2027) | 15.77B | -- | 15.69B | 15.89B | 9 |
FQ2 2027 (Apr 2027) | 15.27B | -- | 15.19B | 15.38B | 12 |
FQ1 2027 (Jan 2027) | 14.93B | -- | 14.62B | 15.13B | 8 |
FQ4 2026 (Oct 2026) | 15.12B | -- | 15.04B | 15.23B | 9 |
FQ3 2026 (Jul 2026) | 15.24B | -- | 14.85B | 16.19B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
1
EPS # of in-lines
2
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | -0.68 | -0.68 | 100% | |
FQ4 2024 (Oct 2024) | 0.68 | 0.68 | 100% | |
FQ3 2024 (Jul 2024) | 0.54 | 0.54 | 100% | |
FQ2 2024 (Apr 2024) | 0.47 | 0.47 | 100% | |
FQ1 2024 (Jan 2024) | 0 | 0 | NAN% | |
FQ4 2023 (Oct 2023) | 0.9 | 0.9 | 100% | |
FQ3 2023 (Jul 2023) | 0.97 | 0.97 | 100% | |
FQ3 1993 (Jul 1993) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | $0B | $13.99B | $13991M | 100% |
FQ4 2024 (Oct 2024) | $0B | $13.84B | $13841M | 100% |
FQ3 2024 (Jul 2024) | $0B | $13.64B | $13642M | 100% |
FQ2 2024 (Apr 2024) | $0B | $12.7B | $12702M | 100% |
FQ1 2024 (Jan 2024) | $0B | $0B | $0M | NAN% |
FQ4 2023 (Oct 2023) | $0B | $14.67B | $14668M | 100% |
FQ3 2023 (Jul 2023) | $0B | $15.2B | $15203M | 100% |
FQ3 1993 (Jul 1993) | $0B | $0.21B | $205.2M | 100% |